It seems the world already has its hands full with rising inflation, ongoing conflicts, and broad geopolitical uncertainty. Now attention has shifted to another public health concern that has appeared in recent weeks: hantavirus, specifically the Andes virus.
Beyond the human health risks (which we will outline below), some market observers are asking whether this outbreak could affect Bitcoin the way COVID-19 did in 2020.
Will History Repeat?
For readers who may not recall March 2020, here’s a brief refresher. Bitcoin was emerging from a lengthy bear market and had not staged a meaningful recovery in 2019. Expectations were high for 2020 because it was a halving year, an event that historically has helped drive later price gains.
Everything changed when the COVID-19 pandemic escalated and was declared a global threat in March 2020. During a rapid two-day sell-off, Bitcoin dropped from over $8,000 to roughly $3,750, a multi-year low.
Some analysts, including prominent social media commentators, have speculated that a severe outbreak of hantavirus could trigger a similar market reaction. One widely shared post compared the diseases’ mortality rates, noting that COVID-19’s early estimated mortality hovered around 1%, while hantavirus has been reported with mortality rates up to 40% in some contexts — a statistic that understandably alarms observers.
WARNING: THE COVID-LIKE $BTC DUMP IS ABOUT TO REPEAT??
COVID mortality rate: ~1%
Hantavirus mortality rate: ~40%The WHO says this likely won’t become the next pandemic.
I don’t think so either.
But they said the same thing about COVID.
Eyes on Bitcoin. pic.twitter.com/F0Dar9gN0n
— Crypto Rover (@cryptorover) May 8, 2026
While social commentary can influence market sentiment, it’s important to weigh biological reality and expert guidance when considering potential economic fallout.
The Differences
The strain under discussion, often referred to as the Andes virus, has been linked to outbreaks in South America and was reported to have caused illnesses and deaths aboard a Dutch cruise ship. Hantaviruses belong to the Hantaviridae family and are typically carried by rodents. Most hantaviruses do not spread from person to person, but the Andes virus is an exception: it is the only hantavirus documented to transmit between humans.
That said, experts emphasize key differences between Andes and highly transmissible respiratory viruses. The Andes virus spreads primarily through close, prolonged contact rather than airborne transmission. Unlike measles or SARS-CoV-2, which can infect people via lingering airborne particles, Andes typically requires intimate exposure, such as shared bedding, sexual contact, or the sharing of food.
“So, when you have people sleeping in the same bed, or sex partners, or people sharing food, the virus can transmit that way. But it doesn’t transmit to huge groups of individuals,” said Steven Bradfute, an immunologist and hantavirus researcher at the University of New Mexico Health Sciences Center.
Because transmission is less efficient, several specialists caution that the virus is unlikely to cause widespread community outbreaks on the scale of COVID-19. Dr. Emily Abdoler and others have stressed that, for most people, the hantavirus should not be among their top concerns.
“I’m doing these interviews as a public service to try to reassure people that this shouldn’t be on their top 100 list of worries,” said Dr. Abdoler.
Those reassurances are helpful, especially given how the seriousness of COVID-19 was initially underestimated. Still, even when an infectious disease poses a limited public health risk, markets can react strongly to uncertainty. Investor sentiment can amplify perceived threats, potentially causing sharp, short-term movements in assets like Bitcoin even if the actual health impact is contained.
In short, while the Andes virus raises legitimate public health questions, current evidence and expert opinion suggest its transmission dynamics differ significantly from those of COVID-19. That lowers the likelihood of a comparable global pandemic, but it does not eliminate the possibility of market volatility driven by fear and speculation. As always, monitoring official public health guidance and maintaining a measured view of market risks remains essential.